Navidea Biopharmaceuticals to Announce Fourth-Quarter and Full-Year 2011 Financial Results on Thursday, March 1, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will host a conference call and live audio webcast at 8:00 a.m. ET on Thursday, March 1, 2012 to provide a business update and discuss its fourth-quarter and full-year 2011 financial and operational results.
MORE ON THIS TOPIC